John V. Kemp
Impact in
- Pharmacology top 5%
- Pharmacogenetics and Drug Metabolism
- Inflammatory mediators and NSAID effects
- Genetics top 10%
- Estrogen and related hormone effects
Papers in
-
- Migraine and Headache Studies 6
- Neurological Complications and Syndromes 2
- Co-authors
- Hugh K. Adam (5 shared papers)John Patterson (3 shared papers)Elaine J. Douglas (1 shared paper)Aaron L. Dane (5 shared papers)Alan E. Wakeling (1 shared paper)Roger Slater (1 shared paper)Jeremy Booth (1 shared paper)KF Ilett (1 shared paper)
- Journals
- The Journal of Clinical Pharmacology (3 papers)Biochemical Pharmacology (2 papers)Xenobiotica (2 papers)British Journal of Clinical Pharmacology (1 paper)European Journal of Clinical Pharmacology (1 paper)
- Partner nations
- United KingdomUnited StatesSwitzerland
In The Last Decade
John V. Kemp
23 papers receiving 644 citations
Peers
Comparison fields: 5 of 91
- Pharmacology 107
- Genetics 219
- Psychiatry and Mental health 92
- Oncology 164
- Medical Terminology 1
Countries citing papers authored by John V. Kemp
This map shows the geographic impact of John V. Kemp's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John V. Kemp with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John V. Kemp more than expected).
Fields of papers citing papers by John V. Kemp
This network shows the impact of papers produced by John V. Kemp. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John V. Kemp. The network helps show where John V. Kemp may publish in the future.
Co-authors
The 25 scholars most cited alongside John V. Kemp, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 23 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2005 | 109 | |
| 2 | 1979 | 83 | |
| 3 | 1983 | 80 | |
| 4 | 1985 | 68 | |
| 5 | Studies on the metabolism and pharmacokinetics of tamoxifen in normal volunteers. | 1981 | 63 |
| 6 | Serum concentrations of tamoxifen and major metabolite during long-term nolvadex therapy, correlated with clinical response. | 1980 | 48 |
| 7 | 2002 | 43 | |
| 8 | 2011 | 34 | |
| 9 | 2002 | 29 | |
| 10 | 2005 | 27 | |
| 11 | 2006 | 22 | |
| 12 | 2002 | 19 | |
| 13 | 1999 | 18 | |
| 14 | 1998 | 14 | |
| 15 | 1982 | 13 | |
| 16 | 2011 | 10 | |
| 17 | 1998 | 9 | |
| 18 | 1989 | 7 | |
| 19 | 2002 | 4 | |
| 20 | 2010 | 4 |
About John V. Kemp
John V. Kemp is a scholar working on Psychiatry and Mental health, Pharmacology, Physiology, Pediatrics, Perinatology and Child Health and Genetics, having authored 23 papers that have together received 710 indexed citations. Recurring topics across this work include Migraine and Headache Studies (6 papers), Estrogen and related hormone effects (4 papers), Nitric Oxide and Endothelin Effects (3 papers), Prenatal Substance Exposure Effects (2 papers), Neurological Complications and Syndromes (2 papers), Sepsis Diagnosis and Treatment (2 papers), PI3K/AKT/mTOR signaling in cancer (2 papers) and HER2/EGFR in Cancer Research (2 papers). The work is most often cited by research in Pharmacology (107 citations), Genetics (219 citations), Psychiatry and Mental health (92 citations), Oncology (164 citations) and Medical Terminology (1 citation). John V. Kemp has collaborated with scholars based in United Kingdom, United States and Switzerland. Frequent co-authors include Hugh K. Adam, John Patterson, Elaine J. Douglas, Aaron L. Dane, Alan E. Wakeling, Roger Slater, Jeremy Booth, KF Ilett, Ruth M Dixon and Jane Kendrew. Their work appears in journals such as The Journal of Clinical Pharmacology, Biochemical Pharmacology, Xenobiotica, British Journal of Clinical Pharmacology and European Journal of Clinical Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.